A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
![A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells](https://files.promab.com/production/RTCA_e2c96be018.jpg)
ProMab has recently had our work published in JoVE on the real-time cytotoxicity assay (RTCA) that we use during our CAR-T cells research and development. Click to learn more!